Effects of nebivolol: A Synthesis of Findings from 13 Studies

  1. Home
  2. Effects of nebivolol
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of nebivolol: A Synthesis of Findings from 13 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of nebivolol: A Synthesis of Findings from 13 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Research Findings

Nebivolol is a beta blocker with vasodilating properties. Multiple studies have shown its efficacy in lowering blood pressure, both systolic and diastolic, in hypertensive patients. 4 , 2 , 8 , 7 , 5 , 9 Nebivolol also has a positive effect on heart rate, lowering it effectively. 11 , 6 Furthermore, nebivolol has been shown to be safe and well-tolerated, even when combined with other antihypertensive medications. 12 , 13 Nebivolol's efficacy is attributed to its ability to selectively block beta-1 adrenergic receptors, leading to vasodilation and a reduction in heart rate. 4 , 2 , 8 , 7 , 11 , 6 , 5 , 9 The study also found that nebivolol's effectiveness is not affected by race. 5

Benefits and Risks

Benefit Summary

Nebivolol is an effective antihypertensive medication with a favorable safety profile. It is well tolerated by patients, even when combined with other antihypertensive medications. 12 It has been shown to effectively lower both systolic and diastolic blood pressure. 4 , 2 , 8 , 7 , 5 , 9 Furthermore, nebivolol reduces heart rate effectively. 11 , 6

Risk Summary

While generally safe and well-tolerated, nebivolol may cause some side effects in certain patients. 7 , 11 It is essential to consult a healthcare professional before taking nebivolol and to follow their instructions carefully.

Comparison of Studies

Similarities

Most studies agree that nebivolol is effective in lowering both systolic and diastolic blood pressure in hypertensive patients. 4 , 2 , 8 , 7 , 5 , 9 Additionally, research consistently shows that nebivolol reduces heart rate effectively. 11 , 6 The studies also indicate that nebivolol is generally safe and well tolerated. 2

Differences

Some discrepancies exist regarding nebivolol's side effects, with certain studies reporting a higher incidence of adverse events than others. 7 , 11

Consistency and Discrepancies in Results

While most research suggests that nebivolol is a safe and effective antihypertensive medication, discrepancies exist regarding the occurrence of side effects. Further research is needed to better understand the long-term safety and efficacy of nebivolol and the factors influencing individual patient responses.

Practical Considerations and Precautions

Consult your doctor before taking nebivolol, as it might interact with other medications you are taking. Nebivolol should be taken as prescribed by your doctor, and the dosage may need to be adjusted depending on your individual needs. It is important to be aware that nebivolol might cause side effects, and you should report any unusual symptoms to your doctor.

Limitations of Current Research

The current body of research on nebivolol is largely limited to short-term studies. Long-term studies are necessary to better understand the long-term safety and efficacy of nebivolol and to identify potential long-term side effects.

Future Research Directions

Further research is needed to investigate the long-term safety and efficacy of nebivolol, particularly in specific populations, such as patients with other underlying health conditions. Exploring strategies to minimize potential side effects is also crucial. Additionally, research into the optimal dosage and combination therapy for nebivolol is warranted.

Conclusion

Nebivolol appears to be a safe and effective treatment option for high blood pressure. It is well tolerated by most patients and has been shown to effectively lower blood pressure, both systolic and diastolic. However, individual responses and the potential for side effects necessitate careful monitoring and a personalized approach to treatment. Further research is necessary to fully understand the long-term effects of nebivolol and identify any potential risks.

Literature analysis of 13 papers
Positive Content
12
Neutral Content
0
Negative Content
1
Article Type
12
0
1
0
13
1.

Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivolol.

Author: De CréeJ, CoboC, GeukensH, VerhaegenH

Effective beta-blocker
Improves left ventricular compliance

Nebivolol, a beta 1-selective adrenergic antagonist, improved left ventricular compliance, potentially by combined effects on preload and afterload.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

2.

Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life.

Author: Van BortelL M, BreedJ G, JoostenJ, KragtenJ A, LustermansF A, MooijJ M

Blood pressure control
Improved quality of life

Nebivolol, a selective beta 1-adrenoceptor antagonist, effectively lowered blood pressure without affecting quality of life perception. It had a favorable safety profile and no evidence of central nervous system side effects.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

3.

Comparison of antihypertensive and beta 1-adrenoceptor antagonist effect of nebivolol and atenolol in essential hypertension.

Author: SimonG, JohnsonM L

Lower blood pressure
Reduced heart rate

Nebivolol is a new beta 1-adrenoceptor antagonist that is ten times more potent than atenolol at lowering blood pressure. In a study of 25 men with essential hypertension, nebivolol and atenolol were equally effective in reducing blood pressure and heart rate at rest and during exercise. Nebivolol is an effective antihypertensive agent.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

4.

Haemodynamic effects and pharmacokinetics of oral d- and l-nebivolol in hypertensive patients.

Author: HimmelmannA, HednerT, SnoeckE, LundgrenB, HednerJ

Lowered blood pressure
Lowered heart rate

Oral nebivolol 5 mg once daily lowered blood pressure and heart rate during steady state compared to placebo. Venous volume was reduced during acute but not steady-state dosing, while peripheral resistance was unaffected in the acute phase but reduced during steady state.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

5.

A dose-response trial of nebivolol in essential hypertension.

Author: Van NuetenL, DupontA G, VertommenC, GoyvaertsH, RobertsonJ I

Effective BP reduction
Well-tolerated

Nebivolol, a cardioselective beta-blocker with nitric oxide-mediated vasodilation, effectively reduced blood pressure in a dose-dependent manner. It was well-tolerated with minimal side effects.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

6.

Nebivolol: comparison of the effects of dl-nebivolol, d-nebivolol, l-nebivolol, atenolol, and placebo on exercise-induced increases in heart rate and systolic blood pressure.

Author: Van NuetenL, De CréeJ

Superior trough-to-peak efficacy ratio

Nebivolol, a beta-blocker, was found to be more effective than atenolol in inhibiting exercise-induced tachycardia. The beta-blocking effects of nebivolol reside in the d-isomer.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

7.

Nebivolol versus nifedipine in the treatment of essential hypertension: a double-blind, randomized, comparative trial.

Author: Van NuetenL, LacourcièreY, VyssoulisG, KorliparaK, MarcadetD M, DupontA G, RobertsonJ I

Improved blood flow
Lowered blood pressure
Edema
Flushing
Headache

This double-blind, randomized trial found that nebivolol was significantly more effective than nifedipine in lowering blood pressure in patients with essential hypertension.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

8.

Nebivolol versus enalapril in essential hypertension: a long-term double-blind comparative trial.

Author: Van NuetenL, Rishøj NielsenM, VertommenC, DupontA G, RobertsonJ I

Lowers blood pressure
Well-tolerated

Nebivolol and enalapril had very similar sustained effects in lowering both systolic and diastolic pressures. Both drugs were well-tolerated.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

9.

Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.

Author: GrassiGuido, TrevanoFosca Quarti, FacchiniAnnalisa, ToutouzasTorakis, ChanuBernard, ManciaGiuseppe

Antihypertensive effect
Better tolerability
Lower side-effect incidence

Nebivolol (5 mg daily) and atenolol (100 mg daily) showed similar antihypertensive effects in a 12-week double-blind randomized study of mild-to-moderate hypertensives. Nebivolol had a better tolerability profile and a lower incidence of side effects.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

10.

Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol.

Author: StoschitzkyKurt, StoschitzkyGergana, BrusseeHelmut, BonelliClaudia, DobnigHarald

Improved QOL
Reduced heart rate
Sleep disturbances

Bisoprolol, carvedilol, and nebivolol all effectively reduce heart rate, but they have distinct effects on peak and trough beta-blocking activity and nocturnal melatonin release. Bisoprolol exhibits stronger peak beta-blocking effects, while nebivolol has the highest trough-to-peak ratio. Only bisoprolol significantly reduced nocturnal melatonin release, potentially leading to sleep disturbances.

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

11.

Comparative effects of conventional B-blockers and nebivolol on psychomotor performances in healthy volunteers: a preliminary report.

Author: KumarA, KhajuriaV, TandonVishal R, KapoorB, SinghR

Psychomotor impairment

This study compared the effects of nebivolol, propranolol, and atenolol on psychomotor performance in healthy volunteers. Single doses of atenolol and propranolol significantly impaired psychomotor performance, and nebivolol had similar effects, likely due to its lipophilic nature.

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

12.

Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension.

Author: PapademetriouVasilios

Blood pressure control
Hypertension treatment

Nebivolol is a beta1-adrenergic receptor blocker with vasodilatory properties. This long-term study demonstrated that nebivolol is safe and effective for treating hypertension, providing long-term blood pressure lowering effects with favorable tolerability.

Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

13.

A Critical Review of Nebivolol and its Fixed-Dose Combinations in the Treatment of Hypertension.

Author: CiceroArrigo F G, KuwabaraMasanari, BorghiClaudio

Arterial stiffness reduction
Endothelial dysfunction improvement
Hypertension treatment
Asthma
COPD
Glucose metabolism
Lipid metabolism

Nebivolol, a β-1 receptor-selective blocker with nitric oxide-mediated vasodilatory effects, is well tolerated by patients with asthma or COPD and has a favorable metabolic profile. Nebivolol is effective in reducing blood pressure and improving endothelial dysfunction and arterial stiffness.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.